ClinConnect ClinConnect Logo
Search / Trial NCT06845475

Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes

Launched by CAIRO UNIVERSITY · Feb 20, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how extracorporeal shockwave therapy can help reduce pain and improve movement in adolescent athletes who have myofascial pain syndrome. Myofascial pain syndrome is a condition where certain areas in the muscles become very tender and can cause pain in other parts of the body. The study aims to see if this therapy can make a difference in how these young athletes feel and perform in their sports.

To take part in this trial, participants need to be between 14 and 18 years old and have specific pain in their neck area that can be pinpointed. They should be able to feel tender spots in their neck muscles, which are known as trigger points. Importantly, even while participating in the study, they can continue with their regular sports activities. However, some individuals may not be eligible if they have certain skin conditions, previous injuries, or are taking pain medications during the study period. This trial is an opportunity for young athletes to explore a potential treatment to help with their pain while staying active.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ranges from 14 to 18 years.
  • All adolescents have regional pain complaint.
  • Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II).
  • Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.
  • Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band.
  • All adolescents are allowed to practice their regular sports activities.
  • Exclusion Criteria:
  • Dermatological disorders.
  • Having myofascial trigger points injection.
  • Chronic pain in both sides of the body.
  • History of findings of cervical injury whether orthopedic or soft tissue injury.
  • Analgesic drugs or NSAIDs during the treatment period.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Ismailia, , Egypt

Patients applied

0 patients applied

Trial Officials

Nanees Essam Mohamed Salem, PhD

Study Chair

Professor, Cairo university

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported